Clinical trials
Active, not recruiting Phase 2 Lung Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
65 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 5 |
| 2019 | 4 |
| 2020 | 12 |
| 2021 | 11 |
| 2022 | 13 |
| 2023 | 4 |
| 2024 | 7 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 65 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 9 |
| National Cancer Institute (NCI) | 7 |
| AstraZeneca | 4 |
| Fundación GECP | 3 |
| Memorial Sloan Kettering Cancer Center | 3 |
| Mirati Therapeutics Inc. | 2 |
| SWOG Cancer Research Network | 2 |
| Swiss Cancer Institute | 2 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Actuate Therapeutics Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 65 |
| Carcinoma, Non-Small-Cell Lung | 31 |
| Adenocarcinoma of Lung | 4 |
| Brain Neoplasms | 4 |
| Breast Neoplasms | 4 |
| Colorectal Neoplasms | 4 |
| Lung Diseases | 4 |
| Neoplasms | 4 |
| Pancreatic Neoplasms | 4 |
| Small Cell Lung Carcinoma | 4 |
Trials
Showing 1 to 25 of 65. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.